Skip to main content
Fig. 3 | Military Medical Research

Fig. 3

From: Pharmacological treatment of inhalation injury after nuclear or radiological incidents: The Chinese and German approach

Fig. 3

Impact of the time of initiation of decorporation treatment on the committed effective doses (mSv) after the inhalation of 1 μCi of Pu-239 as a poorly soluble compound (for example, PuO2) or 1 mCi of Cs-137 as a soluble compound (for example, CsCl). A treatment duration of 30 days is assumed. The committed effective doses without treatment amount to 261 mSv for Pu-239 and 291 mSv for Cs-137. Source of the data: [79]

Back to article page

Military Medical Research

ISSN: 2054-9369